• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    InClinica Names BD Manager

    SCHOTT Introduces syriQ BioPure

    Heritage Pharma Makes Leadership Changes

    JLL and Water Street Acquire Triplefin

    WuXi AppTec Opens Laboratory Testing Facility in NJ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Welcomes Illinois Governor

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    ICON, Intel Enter Pharma Analytics Platform Pact

    AMRI Renews NIH Contract

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Symbiosis Pharmaceutical Services

    Exelead

    Pfizer CentreOne Contract Manufacturing

    SeránCascade

    Fusion Scientific Laboratories
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    MEDIAN Technologies Wins Phase III Imaging Project

    To provide imaging services for multi-site oncology trial

    Related CONTENT
    • Yabao Pharma and Salus Pharma Form Generic Drug Partnership
    • Renaissance to Divest Topical Biz to Mylan
    • Elite, SunGen Pharma in Development and License Agreement
    • Grünenthal Acquires US-based Thar Pharmaceuticals
    • Norgine Buys Merus Labs for $342M
    Kristin Brooks01.30.14
    MEDIAN Technologies has been selected to provide imaging services in a Phase III trial sponsored by a U.S.-based specialty pharmaceutical company, in a transaction valued at $870,400.
     
    Imaging data will be acquired from approximately 24 clinical sites in Europe and Asia, which is expected to enroll 200 patients. MEDIAN will provide clinical site qualification and training, image data collection, quality control, centralized data storage, and Independent Central Review (ICR) services using its Lesion Management Solutions (LMS) software. LMS is a suite of software modules for the review of images and quantitative assessment of response to therapy in trials.
     
    "We are proud of this new project award and enthusiastic about working with both our CRO strategic partner and the specialty pharmaceutical company sponsor on this Phase III study," said Fredrik Brag, chairman and chief executive officer of MEDIAN Technologies. "This award further reinforces the value of our alliance and strengthens our commercial positioning."
    Related Searches
    • CRO
    • Phase III
    • Clinical Trials
    • Information Technology
    Suggested For You
    Solving the Pharma Talent Crunch Solving the Pharma Talent Crunch
    Akebia Therapeutics Names CMO  Akebia Therapeutics Names CMO
    Selexis SA and OSE Immunotherapeutics Enter Pact Selexis SA and OSE Immunotherapeutics Enter Pact
    KBI Biopharma Invests $30M in Facility Upgrades KBI Biopharma Invests $30M in Facility Upgrades
    CROS NT Expands Medidata Pact CROS NT Expands Medidata Pact
    Worldwide Clinical Trials Appoints Clinical Ops VP Worldwide Clinical Trials Appoints Clinical Ops VP
    Hitachi Chemical Acquires Remaining Stake in PCT  Hitachi Chemical Acquires Remaining Stake in PCT
    Aptar Pharma’s Electronic Lockout Device Approved by EMA Aptar Pharma’s Electronic Lockout Device Approved by EMA
    Thermo Fisher Buys Patheon for $7.2B Thermo Fisher Buys Patheon for $7.2B
    Norgine Buys Merus Labs for $342M Norgine Buys Merus Labs for $342M
    Grünenthal Acquires US-based Thar Pharmaceuticals Grünenthal Acquires US-based Thar Pharmaceuticals
    Elite, SunGen Pharma in Development and License Agreement Elite, SunGen Pharma in Development and License Agreement
    Renaissance to Divest Topical Biz to Mylan Renaissance to Divest Topical Biz to Mylan
    Yabao Pharma and Salus Pharma Form Generic Drug Partnership Yabao Pharma and Salus Pharma Form Generic Drug Partnership

    Related Breaking News

    • CRO News
      ICON, Intel Enter Pharma Analytics Platform Pact

      ICON, Intel Enter Pharma Analytics Platform Pact

      ICON to offer the Intel Pharma Analytics Platform for use in clinical trials
      04.20.18

    • Bio News | Collaborations & Alliances | Industry News
      Telix, INSERM, and ARRONAX Enter Agreement

      Telix, INSERM, and ARRONAX Enter Agreement

      To explore the feasibility of using several of Telix's clinical targeting agents with astatine
      04.16.18

    • Bio News | Collaborations & Alliances | Industry News
      Idera, Pillar Partners Enter Agreement

      Idera, Pillar Partners Enter Agreement

      Pillar Partners will provide funding to support three clinical trials to expand the clinical research of Idera's IMO-2125
      04.16.18


    • CRO News
      Pfizer Joins the TriNetX Global Research Network

      Pfizer Joins the TriNetX Global Research Network

      Aims to improve clinical trial design and accelerate drug development
      04.10.18

    • CRO News
      Charles River, PathoQuest Expand Strategic Biologics Pact

      Charles River, PathoQuest Expand Strategic Biologics Pact

      Charles River will provide clients access to PathoQuest’s NGS-based testing solutions
      04.09.18

    • Collaborations & Alliances
      Sciformix, Cambridge Semantics in Technology Platform Pact

      Sciformix, Cambridge Semantics in Technology Platform Pact

      Aims to create enhanced pharmacovigilance automation platform
      04.09.18


    • Bio News | Industry News | Trials & Filings
      FDA Grants FTD to Proteostasis Therapeutics

      FDA Grants FTD to Proteostasis Therapeutics

      For their triple combination program for the treatment of cystic fibrosis
      04.04.18

    • Bio News | Collaborations & Alliances | Industry News
      PTC, CHDI Enter Research Agreement

      PTC, CHDI Enter Research Agreement

      To advance PTC's Huntington's disease program
      04.04.18

    • Bio News | Collaborations & Alliances | Industry News
      IONTAS & IGEM Enter Collaboration

      IONTAS & IGEM Enter Collaboration

      To expand upon IGEM-F, an IgE targeting ovarian and other cancers
      04.04.18


    • Industry News | Promotions & Moves
      Rentschler Biopharma Appoints New VP

      Rentschler Biopharma Appoints New VP

      Dr. Thomas Rösch boasts over 16 years of industry experience, and will head the Biopharma Engineering & Technology unit
      03.28.18

    • CRO News
      Syneos Health Joins Align Clinical CRO

      Syneos Health Joins Align Clinical CRO

      Aims to establish new industry standards to improve clinical trial collaboration and execution
      03.27.18

    • Bio News | Collaborations & Alliances | Industry News
      Catalyst Receives $1.5M in Milestones

      Catalyst Receives $1.5M in Milestones

      After two triggering events for its neuronal nicotinic receptor (NNR) asset TC-6499
      03.26.18

    • Industry News | Trials & Filings
      AMAG Submits NDA to FDA

      AMAG Submits NDA to FDA

      For bremelanotide, for the treatment of acquired, generalized hypoactive sexual desire disorder
      03.26.18

    • Bio News | Breaking News | Industry News | Trials & Filings
      Novartis Meets Primary Endpoint

      Novartis Meets Primary Endpoint

      Fom the Phase III EXPAND study of oral, once-daily siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS)
      03.23.18

    • Promotions & Moves
      Rho Names New QA Director and Clinical Ops VP

      Rho Names New QA Director and Clinical Ops VP

      Lysa Triantafillou and Matt Healy bring extensive clinical research experience
      03.21.18

    Breaking News
    • InClinica Names BD Manager
    • SCHOTT Introduces syriQ BioPure
    • Heritage Pharma Makes Leadership Changes
    • JLL and Water Street Acquire Triplefin
    • WuXi AppTec Opens Laboratory Testing Facility in NJ
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.